Regeneron Pharmaceuticals (Nasdaq: REGN) today announced that the European Commission (EC) has granted conditional marketing ...

The USA faces a serious risk of measles becoming endemic again, according to a new study modeling the impact of declining ...

Shares of French speciality vaccines developer Valneva (Nasdaq: VAL) were down 8.4% at 2.89 euros by early afternoon, after ...

Comac Medical, a full-service contract research organization (CRO) based in Bulgaria, has announced major leadership changes ...

Merck & Co has announced results from the Phase III KEYNOTE-689 trial of Keytruda (pembrolizumab) as a perioperative ...

A new category of diabetes, known as type 5 diabetes, has been officially recognized by the International Diabetes Federation ...

After reported discussions since February, German pharma and sciences company Merck KGaA (MRK: DE) has confirmed its ...

Belgium’s General Association of the Pharma Industry, known as pharma.de, has emphasized the importance of intellectual ...

Hong Kong-based Akeso has announced that the US Food and Drug Administration (FDA) has approved its PD-1 monoclonal antibody, penpulimab-kcqx, alongside cisplatin or carboplatin and gemcitabine, for ...

USA-based Medicus Pharma (Nasdaq: MDCX) has agreed to acquire UK firm Antev for around $75 million in a share exchange deal.

In one of the largest all-private licensing deals so far this year, worth around 500 million euros ($569 million), ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) late Friday announced it has granted a conditional ...